Our Science – Berzofsky Website
Jay A. Berzofsky, M.D., Ph.D.
Selected Publications |
 |
| 1)
Izhak L, Ambrosino E, Kato S, Parish ST, O'Konek JJ, Weber H, Xia Z, Venzon D, Berzofsky JA, Terabe M. Delicate Balance among Three Types of T Cells in Concurrent Regulation of Tumor Immunity. Cancer Res. 73: 1514-23, 2013. [Journal] |
|
| 2)
Ben-Sasson SZ, Hogg A, Hu-Li J, Wingfield P, Chen X, Crank M, Caucheteux S, Ratner-Hurevich M, Berzofsky JA, Nir-Paz R, Paul WE. IL-1 enhances expansion, effector function, tissue localization, and memory response of antigen-specific CD8 T cells. J. Exp. Med. 210: 491-502, 2013. [Journal] |
|
| 3)
Zhu Q, Berzofsky JA. Oral vaccines: Directed safe passage to the front line of defense. Gut Microbes. 4, 2013. [Journal] |
|
| 4)
Rahma OE, Ashtar E, Czystowska M, Szajnik ME, Wieckowski E, Bernstein S, Herrin VE, Shams MA, Steinberg SM, Merino M, Gooding W, Visus C, Deleo AB, Wolf JK, Bell JG, Berzofsky JA, Whiteside TL, Khleif SN. A gynecologic oncology group phase II trial of two p53 peptide vaccine approaches: subcutaneous injection and intravenous pulsed dendritic cells in high recurrence risk ovarian cancer patients. Cancer Immunol. Immunother. 61: 373-84, 2012. [Journal] |
|
| 5)
Berzofsky JA. Improving immunotherapy: revisiting the immunologist's little secret. Sci Transl Med. 4: 120fs4, 2012. [Journal] |
|
| 6)
Zhu Q, Talton J, Zhang G, Cunningham T, Wang Z, Waters RC, Kirk J, Eppler B, Klinman DM, Sui Y, Gagnon S, Belyakov IM, Mumper RJ, Berzofsky JA. Large intestine-targeted, nanoparticle-releasing oral vaccine to control genitorectal viral infection. Nat. Med. [Epub ahead of print], 2012. [Journal] |
|
| 7)
Berzofsky JA, Terabe M, Wood LV. Strategies to use immune modulators in therapeutic vaccines against cancer. Semin. Oncol. 39: 348-57, 2012. [Journal] |
|
| 8)
Sui Y, Berzofsky J. Hefferon K, eds. Vaccine strategies to prevent mucosal transmission of HIV-1. In: Novel Approaches to Vaccine Research, 2011. Kerala: Research Signpost; 2011. p. 137-180 [Book Chapter] |
|
| 9)
Nakashima H, Terabe M, Berzofsky JA, Husain SR, Puri RK. A novel combination immunotherapy for cancer by IL-13Ralpha2-targeted DNA vaccine and immunotoxin in murine tumor models. J. Immunol. 187: 4935-46, 2011. [Journal] |
|
| 10)
Berzofsky JA. A push-pull vaccine strategy using Toll-like receptor ligands, IL-15, and blockade of negative regulation to improve the quality and quantity of T cell immune responses. Vaccine. [Epub ahead of print], 2011. [Journal] |
|
| Click Here to View Expanded Bibliography. |
This page was last updated on 4/5/2013.
